Vilnius 2020 Programme Information

To save session items, please click the heart icons. To view previously saved items, please click Load Favourites.


All Days Fri 20th Sat 21st Free Papers Posters Load Favourites Programme Filter
timer Loading ... please wait
Fri 20 09.15
Chairperson(s):
F. G. Holz; A. Cimbalas
09.15-10.35
Room: ALFA Lecture Hall

Chairpersons: F. G. Holz GERMANY, A. Cimbalas LITHUANIA

09.15
J. Mackiewicz POLAND
Management of submacular hemorrhages in AMD

09.25
N. Eter GERMANY
Pigment epithelial detachments – a diagnsotic and therapeutic challenge

09.35
F. G. Holz GERMANY
Perspectives in AMD therapy

09.45
A. Loewenstein ISRAEL
Continuous release device for nAMD- the Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab End of Study Results

09.55
V. J. Balciuniene LITHUANIA
Retinal disease treatment in Lithuania

10.05
Panel Discussion

10.35
End of session

 

Fri 20 10.35
Chairperson(s):
N. Eter; R. Schlingemann; K. Kaljurand
10.35-11.35
Room: ALFA Lecture Hall

Chairpersons: N. Eter GERMANY , R. O. Schlingemann THE NETHERLANDS, K. Kaljurand ESTONIA

10.35
R. Ochinciuc ROMANIA
Cone density, cone mosaic and fundus autofluorescence results in focal laser-treated central serous chorioretinopathy

10.40
C. Iovino ITALY
Choroidal vascularity index in eyes with retinitis pigmentosa and cystoid macular edema

10.45
M. Ibrahimi UK
Comparing the efficacy of Aflibercept and Ranibizumab for the treatment of moderate to severe neovascular age related macular degeneration

10.50
N. Jurkute UK
Identification of missense variants in SSBP1 expands the autosomal dominant optic atrophy phenotype: From primary retinal ganglion cells dysfunction and optic atrophy to retinal dystrophy

10.55
G. Reiter AUSTRIA
Subretinal drusenoid deposits and photoreceptor loss detecting global and local progression of geographic atrophy by SD-OCT imaging

11.00
X. Chen CHINA
Using 3D-MRI imaging to quantitatively analyze the shape of eyeballs with high myopia and to investigate relationships between myopic traction maculopathy and posterior staphyloma

11.05
I. Etienne BELGIUM
Histological characterization of sodium iodate-induced pathology in rats as a useful model for assessing therapeutic efficacy in age-related macular degeneration

11.10
M. Lindžiūtė LITHUANIA
Diabetic retinopathy and cognitive impairment in type 1 diabetes patients: Is there a connection?

11.15
U. Skirmantaite LITHUANIA
Real-world outcomes of Aflibercept treatment for diabetic macular edema

11.20
D. Veritti ITALY
Simultaneous neutralization of angiopoietin-2 (ANG-2) and vascular endothelial growth factor-a (VEGF-A) with Faricimab: A review of the phase 2 clinical trials in neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)

11.25
Discussion

 

11.35
End of session

Fri 20 12.05
Chairperson(s):
G. Laganovska; S. Wolf; A. Loewenstein
12.05-13.25
Room: ALFA Lecture Hall

Chairpersons: S. Wolf SWITZERLANDA. Loewenstein ISRAEL, G. Laganovska LATVIA

12.05
R. Tadayoni FRANCE
From DRSS to new imaging and AI

12.15
C. Dysli SWITZERLAND
Fluorescence Lifetime imaging

12.25
S. Wolf SWITZERLAND
Automate Biomarker Detection from OCT Scans

12.35
N. Eter GERMANY
Big data in Ophthalmology

12.45
T. Peto UK
Artificial Intelligence for DR screening

12.55
A. Loewenstein ISRAEL
Home monitoring and AI

 

13.05
Panel Discussion

13.25
End of session

Fri 20 14.50
Chairperson(s):
C. Dysli; L. Kuhlewein; E. De Carvalho; E. van Dijk; Y. Subhi
14.50-15.50
Room: ALFA Lecture Hall

Chairpersons: E. De Carvalho UK, L. Kuhlewein GERMANY
Moderators: C. Dysli SWITZERLAND, Y. Subhi DENMARK, E. van Dijk THE NETHERLANDS

14.50
N. Jurkute UK
Beyond the retina, neurological findings on OCT imaging

15.02
G. Godinho PORTUGAL
OCT findings in phakamatoses

15.14
A. Titarenko RUSSIA
OCT features in young patients with retinal vein occlusion

15.26
R. D’Aloisio ITALY 
From small-field to wide-field OCT-A in retinal vascular diseases

15.38
A. Pajtler SLOVENIA
Diseases that mimic wet-AMD: When OCT is not enough

 

15.50
End of session

Fri 20 15.50
Chairperson(s):
A. Loewenstein; S. Wolf; V. Jurate Balciuniene
15.50-17.10
Room: ALFA Lecture Hall

Chairpersons: A. Loewenstein ISRAELS. Wolf SWITZERLAND, V. Jurate Balciuniene LITHUANIA

This session will provide an interactive forum where cases are presented and discussed with the audience and chairperson. Given the nature of the format, cases will not be announced in advance of the session.

Sat 21 09.00
Chairperson(s):
S. Seregard; M. Munk
09.00-10.20
Room: ALFA Lecture Hall

Chairpersons: J. Folke Kiilgaard DENMARKM. Munk SWITZERLAND, R. Zemaitiene LITHUANIA

09.00
E. Miserocchi ITALY 
Ocular manifestation of systemic malignancies

09.10
D. Grewal USA
Pearls for diagnostics to differentiate uveitis, masquerade syndromes and intraocular tumours

09.20
M. Munk SWITZERLAND
Treatment algorithms in uveitis: Managing uveitis in adults and children in the 21th century

09.30
H. Heimann UK 
Update on diagnostics and prognostication for intraocular tumors

09.40
J. Folke Kiilgaard DENMARK
Treatment algorithms of intraocular tumors and complications

 

09.50
Panel Discussion

10.20
End of session

Sat 21 10.30
Chairperson(s):
A. Laidlaw; J. Garcia-Arumi; M. Speckauskas
10.30-11.50
Room: ALFA Lecture Hall

Chairpersons: A. Laidlaw UKJ. Garcia-Arumi SPAIN, M. Speckauskas LITHUANIA

10.30
R. Tadayoni FRANCE
Macular hole surgery Techniques and outcomes

10.40
J. Folke Kiilgaard DENMARK
RD repair and complications

10.50
A. Laidlaw UK
Retinal complications of cataract surgery

11.00
A. Laidlaw UK
Surgical approach of diabetic macular edema

11.10
J. Garcia-Arumi SPAIN
PVR management

11.20
J. Garcia-Arumi SPAIN
Myopic maculopathy

 

11.30
Panel Discussion

11.50
End of session

Sat 21 11.50
Chairperson(s):
R. Tadayoni; A. Laidlaw; T. Peto
11.50-13.10
Room: ALFA Lecture Hall

Chairpersons: R. Tadayoni FRANCEA. Laidlaw UK, T. Peto UK

11.50
T. Peto UK
Medical prevention and screening for diabetic retinopathy

12.00
R. O. Schlingemann THE NETHERLANDS
Pragmatic evidence based management of diabetic maculopathy

12.10
N. Davies UK
Role of anti-veg F in proliferative diabetic retinopathy

12.20
M. Mohammed UK
Proliferative diabetic retinopathy panretinal later when what and how

12.30
A. Laidlaw UK
Vitrectomy in diabetic retinopathy

12.40
R. Tadayoni FRANCE
Evidence-based approach to management of retinal vein occlusion

 

12.50
Panel Discussion

13.10
End of session

Sign up to EURETINA


© EURETINA All rights reserved
Loading please wait